Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Multiomics Market, by Type
1.4.2 North America Multiomics Market, by Product & Service
1.4.3 North America Multiomics Market, by End-use
1.4.4 North America Multiomics Market, by Platform
1.4.5 North America Multiomics Market, by Application
1.4.6 North America Multiomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. North America Multiomics Market by Type
5.1 North America Bulk Multiomics Market by Region
5.2 North America Single-cell Multiomics Market by Region
Chapter 6. North America Multiomics Market by Product & Service
6.1 North America Product Market by Country
6.2 North America Multiomics Market by Product Type
6.2.1 North America Instruments Market by Country
6.2.2 North America Consumables Market by Country
6.2.3 North America Software Market by Country
6.3 North America Services Market by Country
Chapter 7. North America Multiomics Market by End-use
7.1 North America Academic & Research Institutes Market by Country
7.2 North America Pharmaceutical & Biotechnology Companies Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Multiomics Market by Platform
8.1 North America Genomics Market by Country
8.2 North America Transcriptomics Market by Country
8.3 North America Proteomics Market by Country
8.4 North America Metabolomics Market by Country
8.5 North America Integrated Omics Platforms Market by Country
Chapter 9. North America Multiomics Market by Application
9.1 North America Cell Biology Market by Country
9.2 North America Oncology Market by Country
9.3 North America Neurology Market by Country
9.4 North America Immunology Market by Country
Chapter 10. North America Multiomics Market by Country
10.1 US Multiomics Market
10.1.1 US Multiomics Market by Type
10.1.2 US Multiomics Market by Product & Service
10.1.2.1 US Multiomics Market by Product Type
10.1.3 US Multiomics Market by End-use
10.1.4 US Multiomics Market by Platform
10.1.5 US Multiomics Market by Application
10.2 Canada Multiomics Market
10.2.1 Canada Multiomics Market by Type
10.2.2 Canada Multiomics Market by Product & Service
10.2.2.1 Canada Multiomics Market by Product Type
10.2.3 Canada Multiomics Market by End-use
10.2.4 Canada Multiomics Market by Platform
10.2.5 Canada Multiomics Market by Application
10.3 Mexico Multiomics Market
10.3.1 Mexico Multiomics Market by Type
10.3.2 Mexico Multiomics Market by Product & Service
10.3.2.1 Mexico Multiomics Market by Product Type
10.3.3 Mexico Multiomics Market by End-use
10.3.4 Mexico Multiomics Market by Platform
10.3.5 Mexico Multiomics Market by Application
10.4 Rest of North America Multiomics Market
10.4.1 Rest of North America Multiomics Market by Type
10.4.2 Rest of North America Multiomics Market by Product & Service
10.4.2.1 Rest of North America Multiomics Market by Product Type
10.4.3 Rest of North America Multiomics Market by End-use
10.4.4 Rest of North America Multiomics Market by Platform
10.4.5 Rest of North America Multiomics Market by Application
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Illumina, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.2.5.3 Acquisition and Mergers:
11.2.5.4 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 SWOT Analysis
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bruker Corporation
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Qiagen N.V.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Agilent Technologies, Inc.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.7.6 SWOT Analysis
11.8 BGI Group
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.3 SWOT Analysis
11.9 Becton, Dickinson, and Company
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.4.1 Product Launches and Product Expansions:
11.9.5 SWOT Analysis
11.10. Shimadzu Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis
Unique Offerings 